Cargando…
Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records
BACKGROUND: Cardiovascular disease (CVD) risk prediction models for individuals with type 2 diabetes are important tools to guide intensification of interventions for CVD prevention. We aimed to assess the added value of incorporating risk factors variability in CVD risk prediction for people with t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749723/ https://www.ncbi.nlm.nih.gov/pubmed/35776101 http://dx.doi.org/10.1093/ije/dyac140 |
_version_ | 1784850101944975360 |
---|---|
author | Xu, Zhe Arnold, Matthew Sun, Luanluan Stevens, David Chung, Ryan Ip, Samantha Barrett, Jessica Kaptoge, Stephen Pennells, Lisa Di Angelantonio, Emanuele Wood, Angela M |
author_facet | Xu, Zhe Arnold, Matthew Sun, Luanluan Stevens, David Chung, Ryan Ip, Samantha Barrett, Jessica Kaptoge, Stephen Pennells, Lisa Di Angelantonio, Emanuele Wood, Angela M |
author_sort | Xu, Zhe |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) risk prediction models for individuals with type 2 diabetes are important tools to guide intensification of interventions for CVD prevention. We aimed to assess the added value of incorporating risk factors variability in CVD risk prediction for people with type 2 diabetes. METHODS: We used electronic health records (EHRs) data from 83 910 adults with type 2 diabetes but without pre-existing CVD from the UK Clinical Practice Research Datalink for 2004–2017. Using a landmark-modelling approach, we developed and validated sex-specific Cox models, incorporating conventional predictors and trajectories plus variability of systolic blood pressure (SBP), total and high-density lipoprotein (HDL) cholesterol, and glycated haemoglobin (HbA(1c)). Such models were compared against simpler models using single last observed values or means. RESULTS: The standard deviations (SDs) of SBP, HDL cholesterol and HbA(1c) were associated with higher CVD risk (P < 0.05). Models incorporating trajectories and variability of continuous predictors demonstrated improvement in risk discrimination (C-index = 0.659, 95% CI: 0.654–0.663) as compared with using last observed values (C-index = 0.651, 95% CI: 0.646–0.656) or means (C-index = 0.650, 95% CI: 0.645–0.655). Inclusion of SDs of SBP yielded the greatest improvement in discrimination (C-index increase = 0.005, 95% CI: 0.004–0.007) in comparison to incorporating SDs of total cholesterol (C-index increase = 0.002, 95% CI: 0.000–0.003), HbA(1c) (C-index increase = 0.002, 95% CI: 0.000–0.003) or HDL cholesterol (C-index increase= 0.003, 95% CI: 0.002–0.005). CONCLUSION: Incorporating variability of predictors from EHRs provides a modest improvement in CVD risk discrimination for individuals with type 2 diabetes. Given that repeat measures are readily available in EHRs especially for regularly monitored patients with diabetes, this improvement could easily be achieved. |
format | Online Article Text |
id | pubmed-9749723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97497232022-12-15 Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records Xu, Zhe Arnold, Matthew Sun, Luanluan Stevens, David Chung, Ryan Ip, Samantha Barrett, Jessica Kaptoge, Stephen Pennells, Lisa Di Angelantonio, Emanuele Wood, Angela M Int J Epidemiol Cardiovascular Risk Factors BACKGROUND: Cardiovascular disease (CVD) risk prediction models for individuals with type 2 diabetes are important tools to guide intensification of interventions for CVD prevention. We aimed to assess the added value of incorporating risk factors variability in CVD risk prediction for people with type 2 diabetes. METHODS: We used electronic health records (EHRs) data from 83 910 adults with type 2 diabetes but without pre-existing CVD from the UK Clinical Practice Research Datalink for 2004–2017. Using a landmark-modelling approach, we developed and validated sex-specific Cox models, incorporating conventional predictors and trajectories plus variability of systolic blood pressure (SBP), total and high-density lipoprotein (HDL) cholesterol, and glycated haemoglobin (HbA(1c)). Such models were compared against simpler models using single last observed values or means. RESULTS: The standard deviations (SDs) of SBP, HDL cholesterol and HbA(1c) were associated with higher CVD risk (P < 0.05). Models incorporating trajectories and variability of continuous predictors demonstrated improvement in risk discrimination (C-index = 0.659, 95% CI: 0.654–0.663) as compared with using last observed values (C-index = 0.651, 95% CI: 0.646–0.656) or means (C-index = 0.650, 95% CI: 0.645–0.655). Inclusion of SDs of SBP yielded the greatest improvement in discrimination (C-index increase = 0.005, 95% CI: 0.004–0.007) in comparison to incorporating SDs of total cholesterol (C-index increase = 0.002, 95% CI: 0.000–0.003), HbA(1c) (C-index increase = 0.002, 95% CI: 0.000–0.003) or HDL cholesterol (C-index increase= 0.003, 95% CI: 0.002–0.005). CONCLUSION: Incorporating variability of predictors from EHRs provides a modest improvement in CVD risk discrimination for individuals with type 2 diabetes. Given that repeat measures are readily available in EHRs especially for regularly monitored patients with diabetes, this improvement could easily be achieved. Oxford University Press 2022-07-01 /pmc/articles/PMC9749723/ /pubmed/35776101 http://dx.doi.org/10.1093/ije/dyac140 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the International Epidemiological Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cardiovascular Risk Factors Xu, Zhe Arnold, Matthew Sun, Luanluan Stevens, David Chung, Ryan Ip, Samantha Barrett, Jessica Kaptoge, Stephen Pennells, Lisa Di Angelantonio, Emanuele Wood, Angela M Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title | Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title_full | Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title_fullStr | Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title_full_unstemmed | Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title_short | Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records |
title_sort | incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from uk primary care electronic health records |
topic | Cardiovascular Risk Factors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749723/ https://www.ncbi.nlm.nih.gov/pubmed/35776101 http://dx.doi.org/10.1093/ije/dyac140 |
work_keys_str_mv | AT xuzhe incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT arnoldmatthew incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT sunluanluan incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT stevensdavid incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT chungryan incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT ipsamantha incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT barrettjessica incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT kaptogestephen incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT pennellslisa incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT diangelantonioemanuele incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords AT woodangelam incrementalvalueofriskfactorvariabilityforcardiovascularriskpredictioninindividualswithtype2diabetesresultsfromukprimarycareelectronichealthrecords |